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Slices from the brain and liver of rats were prepared and upon incubation exhibited a continuous and high capacity for incorporation of radioactive 
precursors into proteins and lipids. Using PHlmevalonate as precursor, the rates of biosynthesis of cholesterol, ubiquinone, dolichol and dolichyl-P 
in brain slices were determined and found to be 5.5,0.25,0.0093 and 0.0091 nmol/h/g, respectively. Dolichol and dolichyl-P accumulate to a limited 
extent, but almost all of these lipids in the brain originate from de novo synthesis. The calculated half-lives for cholesterol, ubiquinone, dolichol 
and dolichyl-P were 4076, 90, 1006 and 171 h, respectively. The results indicate that lipids formed via the mevalonate pathway in the brain have 
an active and inde~ndently regulated bios~th~is. 
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1. INTRODUCTION pears that these lipids are renewed to very different ex- 
tents in adult rat brain. 
The brain has complete enzymatic systems for 
biosynthesis of the mevalonate pathway lipids, 
cholesterol, ubiquinone, dolichol and dolichyl-P [ 11. 
The chemical composition of the brain differs from 
other organs, since this organ is especially rich in lipids, 
includi~ the end products of the mevalonate pathway 
[2-41. In contrast to several other organs, the uptake of 
lipids from the circulation by the brain is limited, which 
emphasizes the importance of endogenous synthesis. 
Labeling of brain lipids in vivo is difficult, a fact which 
necessitates the use of other systems for studying the 
synthesis of various lipids by this organ. Previous in- 
vestigations have demonstrated that appropriately 
prepared tissue slices synthesize constitutive com- 
ponents at rates proportional to those observed in vivo 
[1,5]. Consequently, such a system is suitable for 
studies on the metabolism of cellular components. 
2. MATERIALS AND METHODS 
Male Sprague-Dawley rats with ages of 2 and 10 months were used. 
All experiments were begun at the same timepoint in the day-night cy- 
cle. The rats were fed standard pellets ad libitum. They were killed 
by decapitation and the brains rapidly removed. The brain was cut in- 
to cubes 0.5 x 0.5 x 1.0 cm in size and placed in cold modified 
minimum essential medium (Plow Laboratories, Irvine). 
The rates of ubiquinone and pol~soprenoid biosyn- 
thesis in brain have not yet been studied, but investiga- 
tions on cholesterol turnover have been performed, 
since the large amount of this lipid in brain makes such 
studies possible. Earlier experiments uggested a very 
low rate of cholesterol synthesis in brain 161, but more 
recent studies indicate that a considerable portion of 
this lipid is continuously renewed [7,8]. It was also pro- 
posed that myelin is present in several compartments 
possessing different turnover times 191. In the present 
investigation the rates of synthesis of products of the 
mevalonate pathway in brain slices were studied. It ap- 
Slices of 5OO~m thickness were subsequently prepared with a 
Polaron H 1200 Vibrating microtome (BioRad, Watford). For 
histological evaluation a paraffin embedded section of the slices was 
stained with hematoxylin~~in. The slices were piaced in flasks con- 
taining 4 ml medium supplemented with 5 mM glucose and 0.7 mM 
unlabeled mevalonate. This concentration is required to minimize the 
effect of dilution by the endogenous pool of mevalonate [5]. Each 
flask contained approximately 0.5 g brain slices and was sup- 
plemented with 0.5 mCi (RS)-5-[3H]mevalonolactone 
(37.9 Cilmmol, New England Nuclear). This system was then in- 
cubated at 37°C. with exposure to carbogen gas (95% 0215% CO2) 
and slow shaking. Incubation was terminated by rinsing the slices in 
cold 0.9% NaCl solution. 
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For measurement of dolichol and dolichyl-P, the homogenates 
were supplied with dolichol-23 and dolichyl-P-23 as internal stan- 
dards and subjected to alkaline hydrolysis, followed by extraction 
with chlorofo~/methanol, 2: 1. For determination of ubiquinone 
and cholesterol, the homogenate were supplied with ubiquinone-6 
and ergosterol as standards and extracted with 
chloroform/methanol, 2: 1, without alkaline hydrolysis. After silica 
and reversed phase chromatography, cholesterol, ubiquinone, 
dolichol and dolichyl-P were separated by HPLC [lO,ll] and their 
radioactivity determined by scintillation counting. The rates of syn- 
thesis were calculated by dividing the total radioactivity appearing in 
the different lipids by the specific activity of the f3H]mev~onate add- 
ed to the incubation flasks. The values obtained were corrected by a 
factor of 4.4 in order to estimate the rate of in vivo synthesis [1,2]. 
In order to take into consideration the different numbers of 
[‘Hlmevalonate molecules incorporated into dolichol, ubiquinone 
and cholesterol, the levels of total radioactivity were divided by 19, 
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Fig. 1. Incorporation of [3H]leucine into total protein, ofj[‘H]glycerol into total phosphotipid and of [-‘H]mevalonate into cholesterol by brain 
slices. (A) After incubation with 2.5 ,&i [3H]ieucine/ml, the slices were rinsed, homogenize, precipitate with 12% cotd Cc13co2H and dissolved 
in 2% sodium dodecyl sulphate in order to measure radioactivity in totai protein. (B) After incubation of slices with 2 pCi [3~~~ycerol/ml, the 
homogenates were extracted with CHCla/MeOH, 2: 1, and phospholipids isolated on a silica column. (C) The homogenate lipids were extracted 
and neutral lipids separated by silica column chromatography followed by isolation of cholesterol on HPLC. The values are the means rt SE 
of values obtained with slices from 5 rats 
9 and 5.5, respectivety (factor K). Consequently, fhe rate of synthesis 
(4.4 x total lipid dpm)f(spec. act. in the precursor pool x K). 
Turnover time was calculated by dividing the concentration of lipid 
in the tissues with the amount of lipid synthesized per hour. Half-life 
(t,,~) was obtained by dividing the turnover time by 1.44 [13]. 
3. RESULTS AND DISCUSSION 
The slices prepared had a constant thickness of 
500 pm and upon histological examination were found 
to possess damaged cells to a limited extent only at the 
cutting surface. In order to investigate the metabolic in- 
tactness of these slices, the time courses of the incor- 
poration of certain precursors into cellular components 
were monitored. Incorporation of j3H]Ieucine into 
trichloroacetic acid-precipitable protein was linear dur- 
ing the 3 h incubation period, demonstrating the 
presence of active protein synthesis (Fig. IA). 
[‘H]Glycerol incorporation into total phospholipid is 
often utilized to follow the biosynthetic rate and a high 
rate of such incorporation could be obtained in slices 
(Fig. 1B). The time course of labeling indicates that 
synthesis of these lipids is also well preserved. Incor- 
poration of [3H]mevalonate into total cholesterol 
(isolated after alkaline hydrolysis) also occurred in a 
linear fashion, further demo~trating that the slices 
prepared are useful for investigation of synthetic pro- 
cesses (Fig. i 1 C). 
In these experiments lices were prepared from the 
brains of rats 2 and 10 months of age and, therefore, 
the lipid com~sition of brain at these ages was deter- 
mined (Table I). At 2 months of age the two largest 
components are phospholipid and cholesterol. The ubi- 
quinone content is 23 ,ug/g wet weight and the 
polyisoprenoid content is also approximately at this 
same level, consisting of 5 times more dolichol than 
dolichyl-P. Eight months later the phospholipid con- 
tent is unchanged and the levels of ubiquinone and 
16 
cholesterol decreased to a great and moderate extent, 
respectively, while dolichol and dolichyl-P levels are in- 
creased. For comparison the lipid content of liver was 
also determined. The changes in liver tissue between 2 
and 10 months were similar to those observed in brain 
with the exception of the cholesterol level, which in- 
creased in liver. 
The rates of synthesis of various products of the 
mevalonate pathway using [‘Hlmevalonate as precur- 
sor are shown in Table II. The rate of ubiquinone syn- 
thesis in brain slices was 20 times less than that of 
cholesterol, while the rates of dolichol and dolichyl-P 
biosynthesis were similar, i.e. around 0.01 nmol/h/g 
tissue. In comparison with liver on a gram basis, the 
rate of cholesterol synthesis in brain was considerably 
less (77 times) and the ratios of the synthetic rates for 
ubiquinone, dolichol and dolichyl-P in liver versus 
brain were 7, 27 and 15, respectively. 
The values in Table I show that during this g-month 
period of the rat’s lifespan, 6.4 pg dolichol and 1.4 pg 
dolichyl-P are accumulated. It can be calculated from 
the values in Table II that during this same time period 
Table I 
Lipid composition of rat brain and liver 
Lipid Brain Liver 
2 months 10 months 2 months 10 months 
Phospholipida 25.2 f 2.9 24.6 f 3.1 23.0 f 2.6 23.1 i 2.6 
Cholesterol’ 12.5 f 1.2 9.4 f 1.0 2.3 f 0.3 5.6 k 0.5 
Ubiquinoneb 23.3 + 2.2 12.8 f 1.4 42.1 + 4.7 19.4 f 2.2 
Dolicholb 17.7 + 2.1 24.1 + 2.9 25.0 + 2.3 63.5 5 5.4 
Dolichyl-Pb 3.2 f 0.4 4.6 4 0.6 9.0 f 1.0 8.7 k 0.9 
The values are the means + SEM of six rats 
a mg/g wet weight 
b fig/g wet weight 
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Table II 
Rate of lipid synthesis in brain slices of 2 month-old rats 
Lipid 
Cholesterol 
Ubiquinone 
Dolichol 
Dolichyl-P 
Brain Liver Liver/brain 
(dpm/g/h) (nmol/g/h) (dpm/g/h) (nmol/g/h) 
1326870 5.5 f 0.6 100360000 416 f 51 77 
98900 0.25 + 0.03 473040 1.8 + 0.23 7.2 
7770 0.0093 + 0.0009 208000 0.25 + 0.03 26.9 
7580 0.0091 + 0.0008 116680 0.14 + 0.02 15.4 
The slices were incubated in the presence of [3H]mevalonate. After incubation the lipids were 
extracted and after silica and reversed phase chromatography, separation was obtained by HPLC 
and calculations were performed as described in section 2. The values are the means + SE of 7 
experiments 
approximately 70 rug dolichol and dolichyl-P are syn- 
thesized. 
The values obtained in Tables I and II were used to 
calculate the half-life of lipids in the brain (Table III). 
Cholesterol has a tljz of about 6 months, while in the 
liver this value is 99 h. The values for ubiquinone, 
dolichol and dolichyl-P are approximately 4, 42 and 7 
days, respectively. The tl/z values for these lipids in the 
liver are between 20 and 50 h. 
The results demonstrate that the lipid products of the 
mevalonate pathway are continuously synthesized in 
the brain, but that the synthetic rates are very different. 
In comparison with liver the rate of cholesterol biosyn- 
thesis is 77 times slower in brain, but the liver values do 
not necessarily represent synthesis of membrane consti- 
tuents only. In the initial phase of synthesis by the liver, 
cholesterol is produced to a large extent for discharge 
into the blood and as precursor for the biosynthesis of 
bile acids. The amount of newly synthesized liver 
cholesterol which is utilized as a component of cellular 
membranes most probably represents only a small frac- 
tion of the total. Therefore, the amount incorporated 
into liver membranes may not be very different from 
that of brain, where cholesterol is not excreted or utiliz- 
ed for the production of active metabolites. 
Ubiquinone biosynthesis, on the other hand, is only 
7 times faster in liver than in brain, in agreement with 
the fact that this lipid is discharged into the bile and cir- 
culation to only a limited extent [14]. Rates of dolichol 
and dolichyl-P biosynthesis are 20 times less in brain 
than in liver, but even in these cases the real differences 
Table III 
Half-lives of lipids in brain 
Lipid Brain (h) Liver (h) 
Cholesterol 4080 99.2 
Ubiquinone 89.6 22.4 
Dolichol 1010 52.9 
Dolichyl-P 171 31.0 
The f1/2 was calculated from Tables I and II as described in section 2 
may be much less. Some export of these lipids to the 
circulation in association with lipoproteins occurs and 
considerable amounts of hepatic dolichol and its 
metabolites are discharged into the bile [14,15]. 
It appears therefore that the rate of synthesis of the 
lipid products of the mevalonate pathway in the brain 
of adult rats occurs at rates which are slower, but 
nonetheless comparable to those seen in the liver. Some 
accumulation of both dolichol and dolichyl-P takes 
place in brain during aging, but this amount is only a 
few percent of that produced by de novo synthesis. 
Clearly, a continuous and active pathway for the 
breakdown of polyisoprenoid compounds must operate 
in adult rat brain in order to maintain a constant 
polyisoprenoid level in the presence of a continuous 
synthesis. 
The values obtained for the biosynthetic rates were 
used to calculate the half-life of the lipids. At present 
there is no direct evidence that these values calculated 
for brain slices are identical to those in vivo, but the 
values for liver are similar to those obtained previously 
using other approaches [la, 171. While the f1/2 values 
for ubiquinone and dolichyl-P in the brain are relative- 
ly short, the tl/z of cholesterol and dolichol are very 
long. The probable explanation for this finding is that 
cholesterol and dolichol are present in different pools 
with very different turnovers. It is also probable that 
both cholesterol and dolichol are not degraded in brain 
[l&19] and slow removal may occur through exchange 
with blood. 
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